I
ron is an essential element that plays vital roles in human health. 1 Thus, not surprisingly, we are surrounded by overthe-counter iron supplements and iron-fortified foods, as iron deficiency disorders are globally more prevalent than iron overload. 2, 3 Yet, most ingested iron, particularly in the form of oral supplements, remains unabsorbed in the intestinal lumen, generally resulting in a large fraction of unabsorbed iron entering the colon. This "iron overloading" of the intestinal tract may very well impact the composition of the gut microbiota because iron availability is fundamental for bacterial growth. In fact, the availability of nutrients along the gut is a major driver of the microbial community structure. 4 The fundamental need of iron to support bacterial growth is highlighted by the disproportionate fraction of the bacterial genome occupied by iron-management strategies, including iron uptake mechanisms. As a growth-limiting micronutrient for many gut bacteria, iron occupies an important place at the interface between the microbiota and the host, raising the question as to how this nutrient impacts the microbiota composition. Past studies have shown that luminal iron depletion in experimental animals have indeed an impact on the gut microbiota composition 5, 6 and on the abundance of antibiotic resistance genes in the gut metagenome. 7 The impact that iron may have on the gut microbiota would be particularly pertinent in individuals who may have a disrupted microbiota (dysbiosis), such as those suffering from chronic inflammatory disorders of the gut, including inflammatory bowel disease (IBD), comprising ulcerative colitis (UC), and Crohn's disease (CD). 8, 9 An increasing number of studies show that the gut microbiota is an essential factor in driving inflammation in IBD. Consistently, patients suffering from IBD have decreased microbial diversity and spatial stability with increased levels of bacteria attaching to the intestinal epithelium [10] [11] [12] [13] [14] and an imbalance between protective and harmful microbes, with similar changes being replicated in mouse models of IBD. Indeed, germ-free mice are protected from colitis, 15 and mice with dysbiosis develop a more severe colitis. 16, 17 The importance of these findings resides in the well-established link between the presence of chronic inflammation in the gut and the risk for the development of colon cancer. [18] [19] [20] Whether the intestinal microbiota is the initiating factor in IBD or secondary to IBD is yet to be resolved. However, there are no doubts that gut dysbiosis in IBD contributes to intestinal inflammation.
Because anemia and iron deficiency are quite common in IBD, 21, 22 iron supplementation is frequently prescribed, with the most used oral iron formulation being ferrous sulfate (FS). 23 However, oral iron has been shown to induce oxidative stress contributing to intestinal inflammation and mucosal damage 24, 25 and to promote oxidative stress-induced carcinogenesis. 26, 27 In addition, iron supplementation and iron-fortified foods may also impact the composition of the gut microbiota, as there is a clear competition between the human host and intestinal microbes, as well as between microorganisms, for iron sources. This is particularly relevant in the inflamed intestine, as the host's immune responses limit iron availability in the gut. This is achieved, for example, through the release of lipocalin 2 (Lcn2), an antimicrobial protein that sequesters iron from bacterial siderophores, into the luminal space. Previous studies investigating the effects of iron supplementation on the gut microbiota and colitis report detrimental 28 as well as beneficial 29 effects regarding colitis severity, whereas studies in patients with IBD found no impact of oral iron supplementation on colitis severity. 30 The later contrast with the negative effects of iron supplementation on the gut microbiota composition and outcomes of infectious diseases reported in African children. 31, 32 Therefore, the effect of iron supplementation on the gut microbial composition and its link to colitis severity remain inconclusive and requires further investigations. Importantly, although iron concentration in the gut has an important influence on changing microbiota composition, the chemical form of iron used may also have an impact. Besides the commonly used ferrous salts, such as FS, 5, 6, 28, 30, 33 a variety of other forms (carbonyl, amino-acid linked) are also available for iron supplementation. For example, ferrous bisglycinate (FBG) chelate, which was developed to provide a safer product with improved bioavailability for food fortification or dietary supplementation. 34 Another iron chelate, ferric ethylenediaminetetraacetic acid (FEDTA), is typically used as a fortificant to improve iron status because it is less affected by inhibitors of iron absorption, and it may actually enhance the bioavailability of intrinsic food iron. 35 In this study, we investigate the effect of doses and diverse iron formulations on the composition of gut microbiota and on the development of chemically induced intestinal inflammation in mice. In addition, we further investigate the possible usage of probiotic bacteria as competitors for iron during colitis flares to counteract the potentially negative effects of oral iron supplementation.
MATERIALS AND METHODS

Animals
C57BL/6 mice were bred and maintained under standard 12:12 hours light/dark conditions at the Centre de recherché du CHUM (CRCHUM). All procedures were performed in accordance with Canadian Council on Animal Care guidelines after approval by the institutional Animal Care Committee of the CRCHUM.
Animal Treatments
Diets
Cohoused female mice from mixed litters (n ¼ 8-10 per group) were fed a purified iron-sufficient diet (50 ppm iron; Teklad TD.120515, Harlan Laboratories, Indianapolis, IN) ad libitum after weaning (;3-4 weeks of age). At 8 to 9 weeks of age (Experimental day 0) the diets were either maintained, or switched to either an iron-deficient diet (,5 mg/kg iron; Teklad TD.120514) or an iron-supplemented diet (500 mg/kg iron; Teklad TD.120517) for 4 weeks. 36 
Dextran Sodium Sulfate (DSS)-induced Acute Colitis
Colitis was induced by the administration of DSS (0.75% W/V of 40,000 molecular weight DSS-TdB Consultancy AB, Uppsala, Sweden) in drinking water of 20 to 25 g female mice for 9 days.
Escherichia Coli Nissle 1917 (EcN) Growth and Administration
EcN (Mutaflor, Medical Futures Inc., Richmond Hill, ON) was grown in LB medium at 378C overnight. One milliliter of the overnight culture was then grown in 100 mL of Luria-Bertani (LB) medium at 378C for 6 hours to an OD 600 of 0.64. Cells were washed with phosphate-buffered saline (PBS) and resuspended in PBS at 10 9 colony-forming units (CFUs) per 200 mL. Serial dilutions of the EcN culture were plated in LB and grown overnight for confirmation of CFU numbers. Mice were treated with 10 9 CFUs of EcN by oral gavage 1 week before DSS administration. A second dosage of 10 9 CFUs was given on the same day the DSS administration was initiated.
Antibiotics
When described, mice received 1 g/L of Streptomycin in drinking water during the DSS treatment. 37 
Histological Scoring of Inflammatory Cell Infiltration
Paraffin sections were stained with hematoxylin and eosin, then subjected to blind analysis and scored as follows: presence of occasional inflammatory cells in the lamina propria (assigned a value of 0); increased numbers of inflammatory cells in the lamina propria (value of 1); confluence of inflammatory cells, extending into the submucosa, (value of 2); and transmural extension of the infiltrate (value of 3).
Quantitative Reverse Transcriptasepolymerase Chain Reaction (qrt-pcr)
Total RNA from homogenized colonic tissue samples was isolated using TRIZOL (Invitrogen, Burlington, ON) followed by a second clean-up done using the Qiagen mRNA isolation kit (Qiagen, Mississauga, ON). Reverse transcription was performed with the Thermoscript RT-PCR system (Invitrogen). Lcn2 and b-actin mRNA levels were measured by real-time PCR in a Rotor Gene 3000 Real Time DNA Detection System (Montreal Biotech, Kirkland, QC) with QuantiTect SYBRGreen I PCR kits (Qiagen) as described. 38 The primers used were b-actin, 
Fecal Iron Concentration
Fecal samples were collected, frozen, and stored at 2208C. The samples were used for quantification of non-heme iron by the Ferrozin assay. 39 
Microbial DNA Extraction and Illumina MiSeq Sequencing
Total DNA was extracted from fecal samples with the Powersoil DNA extraction kit (MO BIO Laboratories, Carlsbad, CA). The amplicon library preparation and sequencing for the stool microbiota analysis was performed by the Genome Quebec Innovation Center. Briefly, amplicon libraries were constructed with the bacterial/archael PCR primers 347F and 803R, which target the V3-V4 region of 16S ribosomal RNA (rRNA) gene. A second PCR was performed to add sample barcodes and the adaptor sequences used by the Illumina sequencing systems. Samples were normalized based on Quant-iT PicoGreen dsDNA Assay Kit (ThermoFisher Scientific, Nepean, ON), pooled and purified with Agencourt AMPure beads (Beckman Coulter Canada Inc., Mississauga, ON). After quality check by DNA quantitation, real-time quantitative PCR and microfluidic gel electrophoresis, the library was sequenced in the MiSeq system (Miseq v2 reagent kit, 500 cycles PE-Illumina, San Diego, CA), spiked with 20% PhiX (Illumina). 
EcN Quantification
Microbiota Analysis
Pre-processing of Sequence Reads
Forward and reverse 16S rRNA gene sequences obtained from Illumina were aligned to each other using the Paired-End Read merger (PEAR 40 ).
Clustering of Reads Into Operational Taxonomic Units (OTUs)
Using the Quantitative Insights Into Microbial Ecology (QIIME 41 ) software, the merged sequences were aligned to the greengenes database version 13.8 (i.e., "closed reference" approach to clustering) containing the sequences for Operational Taxonomic Units (OTUs) devoid of chimeric sequences. We used the 97% similarity database to identify bacteria at the species level. OTUs were filtered to remove taxa present in only one sample and taxa with less than 100 reads across all samples. Samples were confirmed to have a minimum of 1000 reads each.
Alpha-and Beta-diversity Analysis
The Shannon index of diversity was calculated using the R package vegan. 42 To investigate the level of differences between experimental groups (b-diversity, or how are taxa shared between groups), we performed principal coordinate analysis using the weighted UniFrac distance, with the R package phyloseq, and analysis of variance using distance matrices (Adonis) using the R package vegan. 42 
Functional Analysis
To infer sample metagenomes from the 16S rRNA gene analysis (i.e., infer the genes present in the microbiota population), we used the Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) tool with the greengenes version 13.5 precalculated files for the KEGG genes and pathways (because the greengenes OTU database does not change from version 13.5-13.8, the results from the clustering described above were used). The PICRUSt results were then analyzed using linear discriminant analysis effect size to identify microbial functions that were significantly different in their abundance between groups. R 43 was used to generate the graphical outputs.
Statistics
R 43 and Prism were used to perform the statistical analysis. Decision to use nonparametric tests was based on data normality (Shapiro-Wilk test) and homoscedasticity (Bartlett's test) tests. Multiple comparisons were evaluated statistically by 1-way analysis of variance or by Kruskal-Wallis test. Statistically significant differences were then evaluated by two-tailed student's t or Wilcox test. Multiple testing was corrected via False Discovery Rate estimation.
RESULTS
Luminal Iron Concentration Affects Microbiota Composition in the Colon
Most iron delivered through iron supplements in humans remains unabsorbed after ingestion and remains localized in the intestinal lumen, where it may directly impact microbiota composition. To gain further insight onto how luminal iron concentration affects the gut microbiota, we fed C57Bl/6 mice custom made diets containing 10-fold variations in iron content, more precisely 5 mg/kg (iron deficient), 50 mg/kg (iron sufficient), and 500 mg/kg (iron supplemented). As shown in Figure 1A , these diets resulted in approximately 10-fold increases in luminal iron. Thus, in mice, as in humans, most excess iron is retained in the luminal space, allowing successful modulation of luminal iron levels through dietary manipulations.
We next investigated the effect of varying luminal iron concentrations on the microbiota composition in the colon. We analyzed DNA extracted from fecal samples using nextgeneration sequencing of 16S ribosomal RNA (rRNA) gene amplicons on the Illumina platform. As shown in Figure 1B , principal coordinate analysis of the relative abundance of bacterial groups from 16S rRNA transcripts revealed shifts in bacterial communities between mice that were fed the iron-deficient diet and iron-supplemented diet, both showing a partial overlap with the iron-sufficient diet (Adonis: P ¼ 0.008). However, alphadiversity analysis (number of OTUs and Shannon index), shown in Figure 1C , indicated that the diversity of the gut microbiota is not significantly affected by luminal iron levels. 16S rRNA gene analysis revealed that increasing luminal iron levels triggered significant increases of the relative abundance of the bacterial phyla Firmicutes (25% iron deficient versus 30% iron supplemented; P , 0.05), whereas Bacteroidetes and Proteobacteria remained largely unaffected (Fig. 1D) .
Within the phylum Firmicutes, 4 bacterial species increased with luminal iron concentrations (Fig. 1E ), namely members of the orders Clostridiales (unclassified Clostridiales and Oscillospira sp.) and Lactobacilales (Enterococcus sp. and unclassified Enterococcaceae). Conversely, 4 species, belonging to different orders, decreased: order Clostridiales (unclassified Christensenellaceae), order Lactobacilales (Lactococcus sp. and unclassified Lactobacillales), and order SHA-98 (unclassified SHA-98). Changes in unclassified (Mogibacteriaceae) of the order Clostridiales increased from 5 to 50 mg iron/kg chow but decreased from 50 to 500 mg iron/kg chow, suggesting that these specific changes may be unrelated to luminal iron levels. Within the phylum TM7, order CW040, we found a decrease of unclassified F16 with higher iron concentrations. Finally, in the phylum Bacteroidetes, order Bacteroidales, shifts in 4 species were found: Parabacteroides distasonis, Parabacteroides gordonii, Bacteroides cacceae, and unclassified Rikenellaceae.
These results show that variations in luminal iron levels result in a shuffling of abundances rather than significant replacement of community members as the cause of the observed community shifts. Shifts were more frequent for members of the Firmicutes than for the Bacteroidetes or TM7.
Iron Formulations Differentially Affect Colon Microbiota Composition
Next, we asked whether the effect of iron on microbiota composition may differ depending on the iron formulations used to supplement the diet. In the last few decades, several iron compounds have been introduced as food fortificants for the prevention of iron deficiency in humans, selected based on 2 fundamental conditions: (1) "the compound should not change the organoleptic properties of the food vehicle"; and (2) "it should have a high bioavailability when consumed as a final product". 44 We selected 3 commercially available iron compounds of proven bioavailability and distinct complex chemistry that are among the most used as iron fortificants and therapeutic iron supplements: FS, FBG, and FEDTA. 44, 45 As shown in Figure 2A , mice that were fed the different iron formulations at the same iron concentration (i.e., 50 mg iron/kg chow) had similar amounts of luminal iron, therefore excluding the possibility that, should changes in gut microbiota composition be identified, they could be attributable to changes in luminal iron concentration. However, despite similar luminal iron levels, the principal coordinate analysis plot shows that the distinct iron compounds resulted in significantly different clustering of microbiota communities (Adonis: P ¼ 0.03; Fig. 2B ). The number of OTUs and the Shannon index (Fig. 2C) , indicated that the diversity of the gut microbiota was not significantly affected by the distinct iron compounds used in the diets.
While at the phylum level, no significant differences were observed (Fig. 2D) ; at the species level (Fig. 2E) , we found that both FBG and FEDTA, when compared with FS, increased the levels of Parabacteroides sp. (phylum Bacteroidetes). Compared with FS, the abundance of 2 species decreased in response to FBG, namely the Firmicutes unclassified Clostridiaceae and Dehalobacterium sp. of the order Clostridiales. In turn, FEDTA increased the abundance of 6 species: one from the phylum Proteobacteria (Bilophila sp.), 3 Firmicutes (from the order Bacilli -Staphylococcus sciuri and unclassified Lactobacillales; and from the order Erysipelotrichi-Allobaculum sp.), and one from the phylum Actinobacteria (Corynebacterium stationis). Conversely, the abundance of 3 Firmicutes: Lactococcus sp. of the order Lactobacillales, as well as Coprococcus sp. and Roseburia sp. of the order Clostridiales significantly decreased in mice that were fed the FEDTA diet (Fig. 2E) .
Based on equal levels of luminal iron, these data demonstrate that the type of iron compound significantly alters the colon microbiota composition. However, the identified shifts in gut microbiota communities driven by distinct iron formulations are substantially different from the shifts caused by variations in luminal iron levels.
Luminal Iron Levels and Distinct Iron Formulations Induce Changes in Predicted Functional Composition of Fecal Microbiota Communities
Next, to evaluate whether iron-mediated changes in bacterial taxa abundance were accompanied by functional changes, we used PICRUSt 46 analysis applied to the 16S rRNA gene sequencing data. The PICRUSt results were then analyzed using linear discriminant analysis effect size to identify microbial functions that were significantly different between groups. As shown in Figure 3A , a total of 9 differentially abundant bacterial functions were observed (a ¼ 0.05, LDA score .2.5) between mice that were fed the iron-deficient diet (5 mg FS/kg chow) and mice that were fed the iron-supplemented diet (500 mg FS/kg chow). The iron-supplemented diet elevated the number of genes implicated in membrane transport (transporters) and transcription (transcription factors), whereas it decreased the number of genes related to energy metabolism (carbon fixation pathways, oxidative phosphorylation, and energy metabolism), carbohydrate metabolism (citrate cycle), chaperones (folding, sorting and degradation), and metabolism of cofactors and vitamins.
Regarding the effect of iron formulations, analysis of the metagenomes using PICRUSt showed that 5 metabolic pathways were modulated by FBG and 12 by FEDTA when compared with FS. Both compounds led to an increase in genes associated with cellular processes and signaling and a decrease in genes implicated in cell motility (Fig. 3B, C) . There was also an increase in genes that are associated with general functions or poorly characterized genes (Fig. 3B, C) . Overall, the affected metabolic pathways were similar for FBG and FEDTA diets and may therefore represent an effect of the FS diet itself.
Taken together, these data suggest that bacterial community shifts induced by luminal iron concentration reflect both abundance changes and functional changes because, in addition to significant changes in the abundance of particular bacterial taxa, we also found significant modulation of several KEGG pathways. However, distinct iron formulations seem to impact similar inferred metabolic pathways.
Dietary Iron Compounds Differently Impact the Severity of DSS-induced Colitis
Because IBD has been associated with gut dysbiosis, and oral iron supplementation may further affect disease activity, we next investigated the effects of iron supplementation on chemically induced colitis using the 3 different iron compounds, i.e., FS, FBG, and FEDTA. To this end, colitis was induced by adding DSS to the drinking water of mice that were fed the iron-sufficient diet with 50 mg iron/kg chow as ferrous sulfate (FS 50 ), or the ironsupplemented diet with 500 mg iron/kg chow as ferrous sulfate (FS 500 ), ferrous bisglycinate (FBG 500 ), or ferric ethylenediaminetetraacetic acid (FEDTA 500 ). As shown in Figure 4A , mice that were fed the diet supplemented with FBG 500 had the best survival rates (100%), whereas survival in mice that were fed FEDTA 500 was substantially lower (64%). Intermediate survival rates were registered in mice that were fed the FS-supplemented diet (FS 50 -71%; and FS 500 -88%). Accordingly, body weight (Fig. 4B) was also substantially lower in mice receiving FEDTA 500 (19% body loss) and FS 50 (20% body loss), with FBG 500 causing the least body lost (9% body loss), followed by FS 500 (13% body loss). In addition, mucosal cell infiltration assessed in colonic samples, indicating heightened inflammation, was significantly higher in FEDTA 500 and FS 50 fed mice compared with FS 500 or FBG 500 (Fig. 4C) . Finally, mice that were fed the FEDTA 500 supplemented diet developed splenomegaly, which was not observed in the other mouse groups (Fig. 4D) . These data indicate that, overall, FEDTA 500 had the most negative impact on colitis, whereas FBG 500 seems to exert a protective effect. The interpretation that FEDTA aggravated the colitis is further substantiated by the finding that mice in the FEDTA 500 group that did not survive acute colitis had significantly shortened colon length compared with the surviving mice, indicating that mice died from the DSS-induced colitis as opposed to potential toxic effects (Fig. 4E) .
To further establish a link between the worsening of colitis and gut microbiota in mice receiving the FEDTA-supplemented diet, we cotreated mice with streptomycin, a broad-spectrum antibiotic that targets both gram-positive and gram-negative bacteria. This antibiotic, but not vancomycin, neomycin, or penicillin, has been shown by others to reduce colitis in mice treated with DSS, 37 presumably by killing specific bacterial species that contribute to DSS-induced colitis. Therefore, we treated mice that received the FEDTA-supplemented diet with the antibiotic streptomycin during the DSS treatment. As shown in Figure 4F , streptomycin treatment was able to rescue the mice by increasing survival rates to 100%, compared with a 64% survival rate in mice that did not receive antibiotic treatment. Likewise, body weight losses were significantly attenuated in mice receiving streptomycin with both FS-and FEDTA-supplemented diets (Fig. 4G) . These results reinforce the notion that FEDTA affects the outcomes of colitis through microbiota changes as opposed to unspecific toxic effects, in which case mice would have not been rescued by the antibiotic treatment.
Altogether, results from Figure 4 indicate that FEDTA presence in the diet may negatively affect the severity of DSS-induced colitis in mice, most likely through modulation of the microbiota. In contrast, FBG 500 and FS 500 had a protective effect compared with FS 50 , suggesting that iron supplementation may actually have a protective role in colitis.
The Probiotic E. coli Nissle 1917 Requires Iron to Protect Mice from Colitis
The probiotic bacteria EcN has been shown to outcompete pathogenic bacteria such as Salmonella by limiting iron availability and thus limiting their growth. 47 Hence, we next examined the potential use of EcN in combination with iron supplementation in decreasing intestinal inflammation.
To this end, mice were kept on the iron-sufficient diet (FS 50 ) or iron-supplemented diet (FS 500 ) and received 10 9 CFUs of EcN or saline twice, before and at the beginning of the DSS treatment. As shown in Figure 5A , survival rates were lowest when mice were fed the iron-sufficient diet (FS 50 -80%) compared with mice that were fed any of the other diets with or without EcN treatment (100% survival rate). Overall, mice receiving a combination of iron-supplemented diet (FS 500 ) and EcN were the most protected from colitis, as judged by changes in body weight (Fig. 5B) , colon size (Fig. 5C ), inflammation score (Fig. 5D) , and mRNA levels of the inflammatory marker Lcn2 (Fig. 5E) . Again, iron supplementation did not result in aggravation of colitis, recapitulating the results from the previous experiments. The most surprising result was the absence of any protective effect in mice receiving EcN when mice were fed the iron-sufficient as opposed to the iron-supplemented diet. To investigate if this was related to the ability of EcN to grow in an iron sufficient versus iron rich environment, we quantified EcN DNA levels in fecal samples. As shown in Figure 5F , this was not the case, as the quantity of amplified EcN DNA was similar in feces samples collected from both mice that were fed the FS 50 and FS 500 diets.
These data suggest that the protective effect of EcN in colitis depends on the levels of luminal iron, as EcN provided to mice that were fed the FS 50 diet seemed to have no significant effect on protecting mice from DSS-induced colitis, contrasting with the clearly protective effect achieved using the FS 500 diet.
DISCUSSION
Iron fortification and iron supplements are widely used in western countries. However, concerns have been raised as to whether iron supplementation may aggravate inflammation in chronic inflammatory states, such as IBD. Although one of the mechanisms of action for the negative effect of oral iron supplementation may be related to iron's ability to form toxicfree radicals, iron also influences the gut microbial composition, known to play an important role in IBD. In this study, we investigated the effect of diverse iron compounds and doses on the composition and predicted metabolic activity of colon microbiota, as well as on the development of DSS-induced colitis. We further explored the protective effects of a well-characterized probiotic, EcN, given in combination with iron supplementation, on the severity of DSS-induced colitis.
Shifts in Gut Microbiota Composition and the Impact on DSS-Induced Colitis are Driven by Luminal Iron Levels
To investigate the impact of modulating iron concentration in the gut lumen on microbiota composition, we fed mice purified diets supplemented with different concentrations of iron sulfate as the only source of iron. These treatments led to shifts in fecal microbiota composition, but no changes on microbial diversity. Most changes at the phylum level occurred in the Firmicutes which, as a whole, significantly increased with iron supplementation. Our data are consistent with previous findings that mice kept on an iron-deficient diet had a decrease in Firmicutes abundance. 5 Some of the observed modulations may be considered detrimental, such as the decrease in the abundance of Lactococcus sp. at higher iron concentrations, belonging to lactic acid bacteria that are generally considered beneficial. 48 Other microbial shifts are not clearly beneficial or detrimental, for example the shifts in the Enterococcus, another lactic acid bacteria genus, that contains both strains that can induce colitis, 49 and strains that can be used as probiotics. 50 However, some modulations observed in response to elevation of luminal iron levels could be beneficial, such as the increase of Oscillospira sp., reported to be reduced in CD. 51 The increase in Parabacteroides distasonis may also be beneficial as it has been shown to activate Tregs and increase the levels of butyrate, 52 a short chain fatty acid important for gut health. 53 Furthermore, treatment with P. distasonis antigens has been reported to attenuate DSS-induced colitis in mice. 54 Since it is difficult to predict whether the reported shifts in gut microbial composition driven by luminal iron levels are beneficial or detrimental in colitis setting, we directly investigated the impact of modulating luminal iron levels using the DSS-induced colitis model. Iron supplementation seems to have a modest yet still statistically significant protective effect in this colitis model, with increased survival and, in general, improved disease parameters. Although our results seem to be opposite to previous studies reporting that depletion of luminal iron prevents CD-like ileitis in mice, 28 they are in agreement with others showing that oral ferric iron reduces the severity of trinitrobenzene sulfonic acid-induced colitis. 29 A possible explanation for the discrepancy between studies may be related to the animal models used; the TNF-alpha DARE mouse model 28 that affects mostly the small intestine, compared with the DSS-and trinitrobenzene sulfonic acid-induced colitis models 29 which affect mainly the colon. Therefore, results may ultimately reflect differences on the location and pathophysiology of the gut inflammation. More importantly, in both patients with CD and UC, oral iron supplementation does not exacerbate the clinical course of IBD, as evidenced by a recent systematic review of studies evaluating the treatment of iron deficiency anemia in IBD. 23 Similarly, a recent clinical trial in IBD reported no changes in disease activity when comparing oral versus intravenous iron replacement therapy. 30 A possible explanation for the beneficial effects of iron supplementation in our UC model may be related to a recent report revealing that the level of dietary iron reaching the colon has a role in providing the host with beneficial butyrate, via activation of butyrate production by Roseburia. 55 Thus, our study adds further support to the increasing amount of evidence that iron supplementation, while affecting the microbiota composition, does not seem to negatively affect disease activity in IBD. 30 The effects of iron supplementation in IBD are in striking contrast with the reported effects in infants and children in developing countries, with studies showing that dietary iron fortification leads to a significant increase of infectionrelated mortality. The increase in mortality could be partially explained by a significant expansion of facultative pathogenic Enterobacteria, which were present at the beginning of the study. 31 By contrast, IBD is prevalent in western countries, where one would expect fewer problems with gastrointestinal infections and in general, better health care, which may be of relevance for safe oral iron supplementation. This is important, as oral iron supplementation, compared with parenteral iron injections, is safer, 56, 57 cheaper and easier to administer and as such is commonly used to treat iron deficiency anemia in IBD.
Iron Formulations Differentially Affect the Severity of DSS-induces Colitis
Most of the studies on the effects of iron supplementation on the gut microbiota concern iron levels, and do not explore whether the chemical form of dietary iron may also be a determinant of the changes induced in the gut microbiota. To investigate whether the chemical form of iron may distinctly impact the gut microbiota, we fed mice diets supplemented with 3 different iron formulations, namely FS, FBG, and FEDTA. The most striking result was the finding that FEDTA, through changes in microbiota composition, seemed to significantly exacerbate DSS-induced colitis in mice. A possible explanation can be found in the negative modulation of Roseburia sp. by FEDTA. Many members of this bacterial group are butyrate producers 58 and are found at very low levels in patients with IBD when compared with patients without IBD. 59 Our data show that Roseburia sp. abundance decreased to barely detectably levels in mice that were fed the FEDTA-supplemented diet. In addition, other bacteria, such as Allobaculum sp., which is found at high levels in IL-22 2/2 colitic mice 60 as in our mice that were fed the FEDTA diet, may also contribute to the phenotype reported here.
The differential effect of the iron formulation on colitis severity could be due to either the form of iron-ferrous, in FS and FBG; and ferric, in FEDTA-or the iron chelate-sulfate versus BG or EDTA. Ferrous iron may induce oxidative stress by the Fenton reaction. 61 Indeed, high levels of FS have been shown to aggravate oxidative stress in the colon of DSS-treated rats. 62 However, and contrary to what one would expect from its oxidative potential, it is the ferric form used in our studies, i.e., FEDTA, that had the most detrimental effect, and not the ferrous formulations (FS and FBG). Because luminal iron concentrations achieved was similar for all tested iron formulations, this would suggest that the differential effect observed regarding colitis severity and microbiota shifts may be due to the iron chelates, in this case, BG and EDTA. Further support for this interpretation is provided by more recent studies comparing the effects of FS and ferric citrate on microbiota composition using a dynamic, validated, in vitro model of the large intestine (TIM-2), which found no marked differences between these 2 iron preparations. 63 Nevertheless, as a note of caution, our studies were performed using the DSS-induced colitis model. Further studies are therefore necessary to understand whether the reported differential effects on colitis depending on the iron formulation are also replicable in other animal models of colitis, such as trinitrobenzene sulfonic acid 64 and IL-10 knockout 65 mouse models.
This would be important because of the implications of our findings, which are that iron fortification with the ubiquitously used iron fortificant FEDTA may eventually negatively affect patients with IBD. Most food additives are tested for their safety using animal models designed to detect acute toxicity and carcinogenicity, and while FEDTA has been extensively tested and shown to be safe in such models, 35, 66 possible impacts on inflammatory conditions have not been tested. Our observations in mice add to other studies showing that the prevalent usage of certain food additives, such as dietary emulsifiers, may impact chronic inflammatory disease. 66a 
Inferred Metagenome is Modulated by Iron Doses and Formulations
Iron plays an essential role in a diverse number of bacterial cellular processes, for instance, it acts as an enzymatic cofactor in metabolism and for electron transport. Thus, it may not be surprising that bacteria have a transcription factor (ferric uptake regulator-Fur) that directly responds to the levels of intracellular iron. Fur binds iron, dimerizes, and the iron-bound Fur dimers bind to the consensus sequence (Fur binding site) in target promoters (Fig. 3D) , although it has been suggested that iron-free Fur also binds DNA. 67 In bacteria, several genes are modulated through the Fur transcription factor. Interestingly, in addition to the regulation of iron-related genes such as ion transporters, Fur also controls expression genes with "non-iron" functions such as respiration, the Krebs cycle, glycolysis, flagella chemotaxis, motility, DNA synthesis and purine metabolism, among others 68, 69 (Fig. 3D) . Here we find that iron level and form impacted the presence of not only iron-related genes but also some "non-iron" families of genes on the inferred metagenome, including energy metabolism and bacterial chemotaxis genes.
We observed a high number of energy metabolism genes associated with a low iron diet. It is not clear whether there is an association between bacterial energy metabolism and colitis as energy metabolism has been associated with noninflamed mucosa in patients with UC 70 and with remission from active colitis in the T-bet 2/2 RAG2 2/2 UC mouse model, 71 but in patients with CD it is associated with inflamed mucosa. 70 Rooks MG et al 71 found that bacterial motility proteins and flagellar assembly are associated with colitis (compared with remission) in the T-bet 2/2 RAG2 2/2 UC mouse model. In our experiments, in the absence of colitis, we find that genes implicated in cell morphology and motility are associated with both FBG and FEDTA, compared with FS. Beacause in mice subjected to DSS FBG is protective, whereas FEDTA is detrimental, there is no clear association between flagellar assembly and bacterial motility pathways in the models without colitis or in the models with the potential for the development of colitis.
Overall, these changes suggest the presence of functional alterations in the colon microbiota mediated by iron supplementation and formulation, albeit the alterations do not seem to be metagenomic markers of colitis.
Iron Supplementation Potentiates the Protective Effect of the Probiotic EcN in Colitis
Our rationale for testing the use of probiotics during iron supplementation in colitis was based on previous studies showing that iron fortification in Kenyan infants increases pathogen abundance and induces intestinal inflammation. 31 Hence, we aimed to select a probiotic that could compete with pathobionts and pathogens for iron sources and could survive in an inflamed environment. 72 EcN, a clinically approved probiotic, is a facultative anaerobe, has multiple iron acquisition systems 73 and can also bypass Lcn2-mediated host defense by producing a modified syderophore (salmochelin) that is no longer bound by Lcn2. Siderophores are among several virulence factors that are critical for bacteria to successfully colonize the gut. EcN has indeed been shown to successfully outcompete Salmonella for iron in the inflamed gut. 47 Hence, EcN may present several advantages over other anaerobic probiotics that were shown to influence rather modestly the course of IBD. 74, 75 Our results were surprising in that, contrary to what was expected, 76 we found no protection by EcN in mice with DSSinduced colitis that had been fed the iron-sufficient diet (50 mg of iron/kg chow). A possible explanation would be that most standard diets used to feed rodents are in fact high in iron content varying from 250 to 400 mg iron/kg chow, well above what is considered an iron-sufficient diet. Most surprisingly, the protective effect of EcN was significant in DSS-treated mice that were fed the iron excess diet supplemented as FS. Whether other iron formulations, most notably FEDTA, would have similar impact remains to be investigated.
Possible mechanisms by which iron supplementation, at least as FS, potentiate EcN action, may include direct activation/ inactivation of "poison-antidote" systems in EcN. Poison-antidote systems involve the release of bacteriocins (poisons that kill other bacteria, called colicins in E. coli) and antidotes (proteins that render ineffective the bacteriocins). 77 Another type of bacteriocins produced by EcN are microcins, which have been recently shown to mediate competition among Enterobacteriaceae in the inflamed gut. 78 However, microcins are modulated by iron in the opposite direction, that is, microcin production is activated in iron starvation conditions. 79 Although excess iron may directly promote the growth of many gut microorganisms, competition for other nutrients and space may ultimately activate/inactivate poison-antidote system in EcN.
Iron availability has also been shown to affect swarming and biofilm formation in various bacterial species. In fact, high iron availability was shown to promote biofilm formation and inhibit swarming migration, 80 which could affect bacterialepithelial crosstalk ("Host cell signaling"), one of the mechanism proposed for EcN probiotic activity. 81 Finally, excess iron may, eventually, affect other proposed mechanisms of action of EcN involving host responses. For example, EcN has been shown to strengthen tight junctions of intestinal epithelial cells, resulting in the repair of the leaky gut. 82, 83 Our results imply that EcN action can actually be potentiated by iron supplementation and would suggest that EcN is a probiotic of choice when iron supplementation with oral FS preparations is being considered in UC.
CONCLUSIONS
This study investigated the impact of iron doses and forms on microbiota and in DSS-colitis. Our results suggest that the chemical form of iron used for food fortification and as iron supplements may be of importance for patients with IBD, or UC in particular. We report an important detrimental effect of FEDTA on DSS-induced colitis severity in mice, which may suggest that patients with IBD should avoid food consumption fortified with FEDTA or iron supplementation with FEDTA. Finally, the use of the probiotic EcN may be beneficial in combination with oral FS supplementation. Further studies will be necessary to investigate the relevance of our findings in humans.
